DALE GARTH LTD

Company number 12838055 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

DALE GARTH LTD - Analysis Report

Company Number: 12838055

Analysis Date: 2025-07-20 15:29 UTC

Financial Health Assessment for DALE GARTH LTD


1. Financial Health Score: D

Explanation:
DALE GARTH LTD’s financial health is currently fragile, as indicated by consistent net current liabilities and negative shareholders’ funds over recent years. The company is operating with a working capital deficit, which is a symptom of financial distress, albeit not yet at a critical stage. The micro-entity scale limits financial complexity, but the persistent negative equity and increasing current liabilities signal caution.


2. Key Vital Signs

Metric 2023 Value Interpretation
Current Assets £486,157 Healthy cash/resources base; increased significantly from prior years.
Current Liabilities £502,603 High short-term obligations; increased markedly, exceeding current assets.
Net Current Assets -£16,446 Working capital deficit; company cannot cover short-term debts with liquid assets.
Shareholders Funds -£16,446 Negative equity; liabilities exceed assets, indicating cumulative losses or funding gaps.
Average Number of Employees 2 Small operational scale consistent with micro classification.
Share Capital £2 Minimal capital invested by owners, typical for micro-entities but limits financial cushion.

Interpretation of Vital Signs:

  • Working Capital Deficit: The company’s net current liabilities indicate that it has more short-term debts than liquid assets, a significant symptom of financial strain. This is the equivalent of a patient whose blood pressure (liquidity) is below the healthy range, risking systemic issues.
  • Negative Shareholders’ Funds: This suggests accumulated losses or that the company has financed operations largely through liabilities rather than equity. Think of this as the company’s balance sheet showing a “negative net worth,” which undermines financial resilience.
  • Increasing Current Liabilities: The rapid growth in short-term debts may indicate increased reliance on credit or delayed payments, a potential red flag for cash flow management.
  • Current Assets Growth: While current assets have increased, this has not kept pace with liabilities, so the liquidity situation has worsened overall.
  • Micro Entity Status: The company’s small size and limited capital base make it more vulnerable to market or operational shocks.

3. Diagnosis

DALE GARTH LTD is currently in a precarious financial state, exhibiting clear symptoms of liquidity strain and negative net worth. The working capital deficit is a warning sign that the company may struggle to meet its immediate obligations without securing additional financing or improving cash flow. The negative shareholders’ funds reflect an ongoing erosion of financial stability, likely due to losses or extensive borrowing.

This financial “patient” is under stress but not yet in acute failure mode. The absence of overdue filings and the company’s active status are positive signs, suggesting ongoing operations and management engagement. However, the trajectory from 2020 to 2023 shows worsening financial health, akin to a chronic condition that requires intervention to prevent deterioration.

The fact that the company operates in the development of building projects (SIC 41100) might imply exposure to project delays, payment cycles, or market fluctuations, which can further strain cash flow.


4. Prognosis

If current trends persist without corrective measures, the company risks escalating liquidity problems, potential insolvency, or forced restructuring. However, the increasing current assets observed in 2023 indicate some positive cash inflow or asset accumulation, which could be a sign of recovery if managed effectively.


5. Recommendations

  1. Improve Working Capital Management:

    • Tighten credit control and accelerate debtor collections.
    • Negotiate extended payment terms with suppliers to reduce short-term liabilities.
    • Regularly monitor cash flow forecasts to anticipate and manage liquidity gaps.
  2. Capital Injection:

    • Consider increasing equity capital to strengthen the balance sheet and reduce reliance on debt.
    • Explore funding options such as shareholder loans or external investors to provide a financial cushion.
  3. Operational Efficiency:

    • Review project management and cost control to improve profitability and avoid further losses.
    • Evaluate the viability of ongoing projects to prioritize those with better returns.
  4. Financial Reporting and Monitoring:

    • Maintain timely and accurate financial reporting to identify issues early.
    • Consider professional advice for restructuring or turnaround planning if liquidity worsens.
  5. Strategic Planning:

    • Develop contingency plans for market downturns or project delays.
    • Explore diversification or new revenue streams to stabilize cash flow.

Medical Analogy Summary

DALE GARTH LTD is a financial patient showing symptoms of distress — specifically liquidity strain and negative net worth — akin to a person with weakened cardiovascular health due to poor circulation (working capital deficit). Without intervention, the condition may worsen, but with timely treatment (capital infusion, cash flow management), recovery is possible.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.